Philips reports Q1 adjusted EPS EUR 0.25 vs. EUR 0.25 last year

Reports Q1 revenue EUR 4.1B vs. EUR 4.14B last year. Reports Q1 comparable sales down 2%. Reports comparable order intake increased 2% despite China decline. The company said, “We remain dedicated to serving our customers, driving profitable growth and delivering better care for more people. Our order intake growth continued with strong momentum particularly in the US, coupled with positive growth in personal health, providing an encouraging start to the year. In an uncertain macro environment that has intensified due to the potential impact of tariffs, we are focused on what we can control. We are improving our supply chain agility, taking decisive cost actions to mitigate financial impact where possible, and ensuring we can continue to serve our customers and consumers. Patients around the world rely on our medical technology and innovations every day. We are committed to ensuring access to care as we focus on execution, with patient safety and quality as our number one priority.”